德克斯梅德托米丁在治疗难治的疼痛和痴呆症的息治疗患者的使用:一项回顾性研究
Shi-Yuan Yu1, Jacqueline Schellenberg2, Alison Alleyne3
1Department of Pharmacy, Burnaby Hospital, Burnaby, British Columbia, Canada.
PloS one
|September 27, 2023
概括
德克斯梅德托米丁连续皮下输液可能有助于管理息治疗患者的耐火性疼痛,使他们能够保持可用性. 然而,它对妄症状的影响仅限于第一天.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 药理学 药理学是指药理学的学科.
- 症状管理 症状管理
背景情况:
- 息护理患者经常经历难以治疗的症状.
- 米达佐拉姆注射是标准的,但会引起深度镇静.
- 在息治疗中缺乏德克斯梅德托米丁的证据.
研究的目的:
- 描述持续皮下注射德克斯梅德托米丁对耐火性疼痛和妄想的作用.
- 评估德克斯梅德托米丁作为减缓护理中米达佐拉姆的替代品.
主要方法:
- 追溯的,观察图表的回顾.
- 根据SQUIRE指南进行的研究.
- 20名成年癌症患者接受持续皮下注射德克斯梅德托米丁.
主要成果:
- 8/13个疼痛患者显示整体疼痛下降.
- 4/6患有妄想症的患者最初出现了短期的改善.
- 45%的患者有50%或以上的性镇静日.
- 低血压发生在85%的患者中.
结论:
- 德克斯梅德托米丁在息治疗中对治疗不治的疼痛有好处.
- 它使患者能够保持清醒,与传统镇静剂不同.
- 它对狂妄的作用是暂时的,低血压是常见的.
相关概念视频
Parenteral Anesthetics: Overview
151
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
151
Sedatives and Hypnotics Drugs: Miscellaneous Agents
196
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
196
Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326
Stages of General Anesthesia
489
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
489
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
231
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
231


